Mitochondrial DNA damage by bleomycin induces AML cell death
| Autor: | Noel Southall, Danny V. Jeyaraju, Sanduni U. Liyanage, Yan Wu, Mark D. Minden, Paul A. Spagnuolo, Rose Hurren, Marcela Gronda, Samantha A. Hershenfeld, ManTek Yeung, Eric A. Lee, Carine R. Nemr, Rebecca R. Laposa, Wei Zheng, Aaron D. Schimmer, Catherine Z. Chen, Xiaoming Wang, Jeevan Augustine |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Cancer Research
Programmed cell death Mitochondrial DNA Myeloid Clinical Biochemistry Pharmaceutical Science Mice SCID Biology Mitochondrion Bleomycin DNA Mitochondrial chemistry.chemical_compound Cell Line Tumor hemic and lymphatic diseases medicine Animals Humans Cell Proliferation Pharmacology Antibiotics Antineoplastic Cell Death Biochemistry (medical) Cell Biology respiratory system medicine.disease Molecular biology Mitochondria Leukemia Myeloid Acute Leukemia medicine.anatomical_structure chemistry Apoptosis Cell culture Heterografts Neoplasm Transplantation DNA Damage |
| Zdroj: | Apoptosis. 20:811-820 |
| ISSN: | 1573-675X 1360-8185 |
| DOI: | 10.1007/s10495-015-1119-z |
| Popis: | Mitochondria contain multiple copies of their own 16.6 kb circular genome. To explore the impact of mitochondrial DNA (mtDNA) damage on mitochondrial (mt) function and viability of AML cells, we screened a panel of DNA damaging chemotherapeutic agents to identify drugs that could damage mtDNA. We identified bleomycin as an agent that damaged mtDNA in AML cells at concentrations that induced cell death. Bleomycin also induced mtDNA damage in primary AML samples. Consistent with the observed mtDNA damage, bleomycin reduced mt mass and basal oxygen consumption in AML cells. We also demonstrated that the observed mtDNA damage was functionally important for bleomycin-induced cell death. Finally, bleomycin delayed tumor growth in xenograft mouse models of AML and anti-leukemic concentrations of the drug induced mtDNA damage in AML cells preferentially over normal lung tissue. Taken together, mtDNA-targeted therapy may be an effective strategy to target AML cells and bleomycin could be useful in the treatment of this disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink